指南与共识神经MR

2024 MAGNIMS-CMSC-NAIMS共识建议:MRI在多发性硬化诊断中的应用

2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis.
指南 / 共识 · Lancet Neurol · 2025-01-01

该共识讨论MRI在2024 McDonald多发性硬化诊断标准中的扩展作用,包括视神经作为第五解剖位置,并推荐全脑及脊髓的适当成像策略与MRI采集方案,涵盖磁化率敏感序列评估中央静脉征和顺磁性边缘病灶,以及影像解读、避免误诊和标准化建议。

要点

  • 2024 McDonald标准将视神经列为第五解剖位置,空间多发需至少四个典型位置病灶。
  • 诊断成像应覆盖脑和脊髓,并包括磁化率敏感序列评估中央静脉征和顺磁性边缘病灶。
  • 推荐使用脂肪饱和序列检测症状性视神经病变,并标准化MRI采集与结果沟通。

核心结论

  • MRI在2024 McDonald多发性硬化诊断标准中作用扩展,视神经成为第五解剖位置,满足空间多发标准可确诊。
  • 推荐适当的成像策略和MRI采集协议用于多发性硬化诊断的所有方面,包括脂肪饱和序列检测症状性视神经病变。

研究设计与样本

  • 制定机构:MAGNIMS、CMSC和NAIMS;方法:共识建议;证据分级:原文未报告。

关键影像表现/征象

  • 中央静脉征和顺磁性边缘病灶在磁化率敏感序列上可见,当常规影像不足以确诊时尤其有帮助。
  • 典型病灶分布于脑室周围、近皮质或皮质、幕下、脊髓和视神经五个解剖位置。

诊断标准与关键数值

  • 2024 McDonald标准:空间多发需至少四个典型位置(脑室周围、近皮质或皮质、幕下、脊髓、视神经)的典型病灶,无额外证据即可确诊。
  • 诊断成像应始终覆盖脑和脊髓,并包括磁化率敏感序列评估中央静脉征和顺磁性边缘病灶。

临床应用与阅片要点

  • 推荐使用脂肪饱和序列检测症状性视神经病变。
  • 推荐对放射学孤立综合征进行诊断管理,该表现已纳入2024标准。
  • 提供图像解读和避免误诊的建议,并将推荐扩展至老年人、儿童、血管共病或偏头痛患者及欧洲和北美以外人群。
  • 推荐标准化MRI采集和结果沟通,以实现更早诊断同时保持高诊断特异性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

MRI plays an increasingly important role in the diagnosis of multiple sclerosis. We discuss the expanded role of MRI in the 2024 McDonald diagnostic criteria for multiple sclerosis, which include the optic nerve as a fifth anatomical location, in addition to the periventricular, juxtacortical or cortical, infratentorial, and spinal cord regions. The diagnosis of multiple sclerosis can now be confirmed when the criteria of dissemination in space are fulfilled with the detection of typical lesions in at least four locations without additional evidence. We recommend appropriate imaging strategies and MRI acquisition protocols for all aspects of multiple sclerosis diagnosis, including fat-saturated sequences for detection of symptomatic optic nerve lesions. Diagnostic imaging should always cover the brain and spinal cord and include susceptibility-sensitive sequences for the assessment of the central vein sign and paramagnetic rim lesions, which can be especially helpful in cases when conventional imaging findings are insufficient to establish a diagnosis. We discuss how to handle the diagnosis of radiologically isolated presentations of multiple sclerosis, which are included in the 2024 criteria. We present recommendations for image interpretation and avoidance of misdiagnosis, and extend the recommendations to the use of MRI in the diagnosis of multiple sclerosis in older people, children, people with vascular comorbidities or migraine, and people living outside Europe and North America. Finally, we provide recommendations for standardisation of MRI acquisition and communication of results to enable an earlier diagnosis while maintaining high diagnostic specificity.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Barkhof F, Reich DS, Oh J, et al. 2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis. Lancet Neurol. 2025. PMID: 40975102. doi:10.1016/S1474-4422(25)00304-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。